• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

No More Yearly Flu Shots? Vaccine Mixed From 80,000 Proteins Could Be The Key

May 2, 2024 by Deborah Bloomfield

A new vaccine strategy could spell the end of yearly flu shots, by targeting part of the virus that is much less prone to mutations. So far, it’s worked well in mice and ferrets – could we soon be looking at a human equivalent?

Why do we need to get a flu vaccine every year?

Seasonal flu is responsible for roughly half a million deaths every year. It can be a very serious disease, and spreads easily between people, so vaccines that prime our immune system to recognize proteins on the virus’s surface are our best possible defense. 

Advertisement

Unfortunately, the flu virus also has an irritating habit of mutating. A lot. That means we have to constantly update the vaccine to try and keep up. Each year, scientists study the trends from previous flu seasons and tailor the vaccine to the strains of virus they think will be most prevalent.

It’s not a perfect system, and some year’s flu vaccines are better than others, but it does save lives.

What does the flu vaccine target?

The two major surface proteins on an influenza virus are called hemagglutinin and neuraminidase. The different types of these proteins give each strain a shorthand name – you may have heard of H5N1 or H1N1. The H, sometimes abbreviated to HA, is what we’re most interested in.

“On the virus particle, there’s five to 10 times more hemagglutinin than neuraminidase,” said associate professor of molecular genetics and microbiology Nicholas Heaton in a statement. “If we took your blood to see if [you are] likely to be protected from a strain of flu, we’d be measuring what your antibodies do to hemagglutinin as the best metric of what’s likely to happen to you.

Advertisement

“The strongest correlates of protection have to do with hemagglutinin-directed immunity.”

How is this new vaccine approach different?

“A number of groups have gone through and experimentally mutagenized the whole hemagglutinin and asked ‘which areas can change and still allow the hemagglutinin to function?’ And the answer is, you can’t really change the stalk and expect it to continue to function,” Heaton said.



The “head” of the hemagglutinin protein is constantly changing as the virus is locked in an arms race with the human immune system. Heaton and the team came up with a way to get the immune system to shift its focus to a new target instead: the stalk.

The team generated some 80,000 different variants of hemagglutinin, each with small changes in one section at the top of the head. They mixed a vaccine cocktail of these variants and injected it into mice and ferrets. We don’t see ferrets cropping up in the lab all that often, but they’re a very good model organism for the study of influenza. 

Advertisement

Because the hemagglutinin heads being presented to the immune system via the vaccine were all different, whereas the stalks were consistent, this altered the balance of antibodies being generated by the immune system. 

Antibodies against the stalk of the protein work differently than those against the head. By creating a vaccine that generates both types of antibodies, Heaton and the team hoped to give the immune system a better chance even if the seasonal strains selected for the vaccine weren’t quite right, or in case a whole new pandemic strain should come along.

“Essentially, the paper says, Yes, we can accomplish that,” said Heaton.

What were the results?

Well, they were pretty impressive. In some of the mouse experiments, 100 percent of the animals avoided illness or death when given a dose of flu that should have been fatal. Across the ferret experiments, the animals given the new vaccine had less severe illness than those given an old-style shot.

Advertisement

However, it’s a little early to get excited. If you want up-to-date protection, you’re going to be scheduling in that annual shot for a good few years yet.

One of the important caveats the authors note in their paper is that the animals they used had no pre-existing immunity to flu. This is not the case for pretty much every human who is not a newborn baby, so it will be important to find out how this approach works in people with a history of previous vaccine or illness. 

They also only used one specific type of hemagglutinin, and as we know there are many others out there. More work is needed to completely tease apart the mechanism by which the vaccine prevented serious disease in the animals, and the scientists are also keen to find out whether it can work with fewer than 80,000 different variants.

section of tapestry from the National Institute for Medical Research's World Influenza Centre commemorating the identification of the flu virus in 1933, with a photo of a ferret next to diagrams of the virus

Ferrets and flu go back a long way – it’s thanks to them that we first discovered the virus in 1933.

Image credit: Yipu Lin (WHO Influenza Centre)/NIMR London via Flickr (CC BY 2.0)

All of these questions will hopefully be answered in future studies, and human trials would of course be needed before you could rock up to Walgreens and get your universal flu shot. The results form part of a five-year project – these things are marathons, not sprints. 

Advertisement

We might have allowed ourselves to forget, just for a second, what flu can do while our attention was necessarily focused on COVID-19. But with H5N1 avian flu making concerning moves, and this year’s annual season already underway in the Southern Hemisphere, it’s good to think that the universal vaccine we’ve been hoping for is a step closer to fruition.

The study is published in Science Translational Medicine. 

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Events leading up to the trial of Theranos founder Elizabeth Holmes
  2. “Man Of The Hole”: Last Known Member Of Uncontacted Amazon Tribe Has Died
  3. This Is What Cannabis Looks Like Under A Microscope – You Might Be Surprised
  4. Will Lake Mead Go Back To Normal In 2024?

Source Link: No More Yearly Flu Shots? Vaccine Mixed From 80,000 Proteins Could Be The Key

Filed Under: News

Primary Sidebar

  • Project Hail Mary Trailer First Look: What Would Happen If The Sun Got Darker?
  • Newly Discovered Cell Structure Might Hold Key To Understanding Devastating Genetic Disorders
  • What Is Kakeya’s Needle Problem, And Why Do We Want To Solve It?
  • “I Wasn’t Prepared For The Sheer Number Of Them”: Cave Of Mummified Never-Before-Seen Eyeless Invertebrates Amazes Scientists
  • Asteroid Day At 10: How The World Is More Prepared Than Ever To Face Celestial Threats
  • What Happened When A New Zealand Man Fell Butt-First Onto A Powerful Air Hose
  • Ancient DNA Confirms Women’s Unexpected Status In One Of The Oldest Known Neolithic Settlements
  • Earth’s Weather Satellites Catch Cloud Changes… On Venus
  • Scientists Find Common Factors In People Who Have “Out-Of-Body” Experiences
  • Shocking Photos Reveal Extent Of Overfishing’s Impact On “Shrinking” Cod
  • Direct Fusion Drive Could Take Us To Sedna During Its Closest Approach In 11,000 Years
  • Earth’s Energy Imbalance Is More Than Double What It Should Be – And We Don’t Know Why
  • We May Have Misjudged A Fundamental Fact About The Cambrian Explosion
  • The Shoebill Is A Bird So Bizarre That Some People Don’t Even Believe It’s Real
  • Colossal’s “Dire Wolves” Are Now 6 Months Old – And They’ve Doubled In Size
  • How To Fake A Fossil: Find Out More In Issue 36 Of CURIOUS – Out Now
  • Is It True Earth Used To Take 420 Days To Orbit The Sun?
  • One Of The Ocean’s “Most Valuable Habitats” Grows The Only Flowers Known To Bloom In Seawater
  • World’s Largest Digital Camera Snaps 2,104 New Asteroids In 10 Hours, Mice With 2 Dads Father Their Own Offspring, And Much More This Week
  • Simplest Explanation For “Anomalous” Signals Coming From Underneath Antarctica Ruled Out
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version